This interview provides a short introduction to the NMT Infusion controller use case in the EU-funded project VALU3S. The main objective has been the development of a testbench platform for evaluation of a closed loop delivery system for relaxation drugs infusion under controlled conditions. The objective is to keep NMT vital signs within a predefined target band. One of the most important achievements has been to be able to simulate the real life conditions in a laboratory environment. The fact that the patient can be simulated, makes it possible to be able to test the infusion controller under varying patient’s conditions such as age, gender, sensitivity to drug, pathologies, etc.
Watch interview here.
